GR3021292T3 - Lipopeptide deacylase - Google Patents

Lipopeptide deacylase

Info

Publication number
GR3021292T3
GR3021292T3 GR960402663T GR960402663T GR3021292T3 GR 3021292 T3 GR3021292 T3 GR 3021292T3 GR 960402663 T GR960402663 T GR 960402663T GR 960402663 T GR960402663 T GR 960402663T GR 3021292 T3 GR3021292 T3 GR 3021292T3
Authority
GR
Greece
Prior art keywords
enzyme
deacylase
lipid
cyclicpeptide
aculeacin
Prior art date
Application number
GR960402663T
Other languages
English (en)
Inventor
Adam Joseph Kreusman
Wu-Kuang Yeh
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of GR3021292T3 publication Critical patent/GR3021292T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y10S435/815—Enzyme separation or purification by sorption

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
  • Peptides Or Proteins (AREA)
GR960402663T 1990-06-07 1996-10-09 Lipopeptide deacylase GR3021292T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53439490A 1990-06-07 1990-06-07

Publications (1)

Publication Number Publication Date
GR3021292T3 true GR3021292T3 (en) 1997-01-31

Family

ID=24129856

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960402663T GR3021292T3 (en) 1990-06-07 1996-10-09 Lipopeptide deacylase

Country Status (14)

Country Link
US (1) US5573936A (el)
EP (1) EP0460882B1 (el)
JP (1) JP2994486B2 (el)
KR (1) KR0169994B1 (el)
AT (1) ATE140728T1 (el)
CA (1) CA2043762C (el)
DE (1) DE69121018T2 (el)
DK (1) DK0460882T3 (el)
ES (1) ES2089133T3 (el)
GR (1) GR3021292T3 (el)
HU (1) HU215232B (el)
IE (1) IE75885B1 (el)
IL (1) IL98349A (el)
TW (1) TW197471B (el)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743777B1 (en) 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
ATE544851T1 (de) 1996-03-08 2012-02-15 Astellas Pharma Inc Verfahren zur deacylierung von zyklischen lipopeptiden
US6146872A (en) * 1996-06-13 2000-11-14 Fukisawa Pharmaceutical Co., Ltd. Cyclic lipopeptide acylase
US6361988B1 (en) 1997-03-25 2002-03-26 California Institute Of Technology ECB deacylase mutants
US6153410A (en) * 1997-03-25 2000-11-28 California Institute Of Technology Recombination of polynucleotide sequences using random or defined primers
US5936074A (en) * 1997-04-17 1999-08-10 Eli Lilly And Company Teicoplanin deacylation process and product
US6323176B1 (en) 1998-02-25 2001-11-27 Eli Lilly And Company Cyclic peptide antifungal agents
WO2000034315A2 (en) 1998-12-09 2000-06-15 Eli Lilly And Company Purification of echinocandin cyclopeptide compounds
ES2270819T3 (es) 1999-03-03 2007-04-16 Eli Lilly And Company Formacion e intercambio anionico de sales de amonio internas cristalinas de equinocandina.
CA2362482A1 (en) 1999-03-03 2000-09-08 Eli Lilly And Company Processes for making pharmaceutical oral ecb formulations and compositions
AU776782C (en) 1999-03-03 2005-04-07 Eli Lilly And Company Echinocandin pharmaceutical formulations containing micelle-forming surfactants
RU2001126723A (ru) 1999-03-03 2003-09-27 Эли Лилли энд Компани (US) Эхинокандин/углеводные комплексы
CA2378868A1 (en) * 1999-07-15 2001-01-25 Eli Lilly And Company Process for deacylation of lipodepsipeptides
WO2001044272A2 (en) * 1999-12-15 2001-06-21 Cubist Pharmaceuticals, Inc. Daptomycin analogs as antibacterial agents
CA2394313A1 (en) * 1999-12-15 2001-06-21 Cubist Pharmaceuticals, Inc. Novel lipopeptides as antibacterial agents
BR0016467A (pt) * 1999-12-15 2002-08-27 Cubist Pharm Inc Lipopeptìdeos como agentes antibacterianos
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
DE60232158D1 (de) * 2001-08-06 2009-06-10 Cubist Pharm Inc Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
DE102004060750A1 (de) * 2004-12-15 2006-07-13 Sanofi-Aventis Deutschland Gmbh Verfahren zur Deacylierung von Lipopeptiden
PL2379580T3 (pl) * 2008-12-22 2014-05-30 Merck Sharp & Dohme Nowe środki przeciwbakteryjne do leczenia zakażeń wywołanych bakteriami Gram-dodatnimi
US9394340B2 (en) * 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides
CN104768966B (zh) 2012-09-24 2018-11-02 中化帝斯曼制药有限公司荷兰公司 生产环肽的方法
KR101425108B1 (ko) * 2012-09-25 2014-07-31 동국제약 주식회사 탈아실화된 환상 리포펩티드의 제조방법
CN108410929B (zh) * 2018-05-30 2024-01-26 博瑞生物医药（苏州）股份有限公司 阿尼芬净前体的制备方法
CN109593809A (zh) * 2018-12-07 2019-04-09 成都雅途生物技术有限公司 一种固定化微生物酶转化棘白菌素b的方法
CN113215185B (zh) * 2021-04-22 2022-04-29 浙江工业大学 一种用于重组表达棘白菌素b脱酰基酶的重组基因序列

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1159450A (en) * 1979-12-13 1983-12-27 Manuel Debono Process for the preparation of derivatives of cyclic peptide nuclei

Also Published As

Publication number Publication date
US5573936A (en) 1996-11-12
IE911939A1 (en) 1991-12-18
EP0460882A2 (en) 1991-12-11
TW197471B (el) 1993-01-01
HUT61587A (en) 1993-01-28
DE69121018T2 (de) 1996-12-19
HU215232B (hu) 1998-11-30
KR0169994B1 (ko) 1999-02-01
ES2089133T3 (es) 1996-10-01
IL98349A0 (en) 1992-07-15
IE75885B1 (en) 1997-09-24
DK0460882T3 (da) 1996-08-26
CA2043762C (en) 2001-05-29
EP0460882B1 (en) 1996-07-24
JP2994486B2 (ja) 1999-12-27
JPH04228072A (ja) 1992-08-18
KR920000919A (ko) 1992-01-29
HU911897D0 (en) 1991-12-30
IL98349A (en) 1995-05-26
CA2043762A1 (en) 1991-12-08
ATE140728T1 (de) 1996-08-15
EP0460882A3 (en) 1992-04-22
DE69121018D1 (de) 1996-08-29

Similar Documents

Publication Publication Date Title
TW197471B (el)
ES2124295T3 (es) Expresion y purificacion de factor tisular soluble recombinante.
DE69332879D1 (de) Technetium-99-markierte peptide zur visualisierung vom entzuendungen
NZ332625A (en) Concentrated antibody preparation containing greater than 100 mg/ml of the antibody
DK163520C (da) Substitueret androsta-1,4-dien-3,17-dioner, fremgangsmaade til fremstilling deraf, praeparater indeholdende saadanne forbindelser samt anvendelsen af disse til fremstilling af farmaceutiske praeparater
DK0464140T3 (da) Aktivt adhæsionspeptid
ES2179077T3 (es) Acido glutamico decarboxilasa clonada.
PT1062325E (pt) Purificacao de preparacoes de virus
DK289285D0 (da) Thymopentin analoge
EP0300031A4 (en) IMMUNE SUPPRESSIVE PEPTIDES AND METHOD FOR THEIR USE.
JPH02500022U (el)
GB9311454D0 (en) Pharmaceutical compositions
MY119366A (en) A process for the preparation of factor ix from biological sources
AP9100296A0 (en) Peptides and analogues and mixtures thereof for detecting antibodies to HTLV-1 and HTLV11 viruses.
ES2195409T3 (es) Purificacion de moleculas.
AU7796291A (en) High affinity antibodies to small peptides
SANTIS Spherical cap harmonic analysis of local gravity field
EP0351790A3 (de) Verfahren zur Bestimmung von Fructosamin
AU8125991A (en) Apparatus for blending gaseous or vaporous substances
EP0389318A3 (en) Procedure for helping navigation and improved terrestrial navigation system
Lopez-Trascasa et al. Isolation and characterization of a biologically active C2 derived oligopeptide
Monahan et al. Studies of the interaction of C8 and C9 within the membrane-bound cytolytic complex of complement
Smith et al. Ultrastructural studies of the human complement components C3 and factor B and of cobra venom factor (CVF)
Widdowson Abstraction, Actuality and the Conditions of Relevance
BLUFORD Applying science in space to practical needs